First Capital Advisors Group, Llc. Biogen Inc. Transaction History

First Capital Advisors Group, Llc.

$188 Million
Q2 2023

A detailed history of First Capital Advisors Group, Llc. transactions in Biogen Inc. stock. As of the latest transaction made, First Capital Advisors Group, Llc. holds 1,859 shares of BIIB stock, worth $419,483. This represents 0.28% of its overall portfolio holdings.

Number of Shares

1,859

Previous 1,551 19.86%

Holding current value

$419,483

Previous $431,000 22.74%

% of portfolio

0.28%

Previous 0.28%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$275.25 - $318.06 $84,777 - $97,962	308 Added 19.86%	1,859 $529,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $2,565 - $2,923	-10 Reduced 0.64%	1,551 $431,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $20,700 - $25,151	-82 Reduced 4.99%	1,561 $432,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $95,398 - $131,545	-490 Reduced 22.97%	1,643 $439,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $400,022 - $475,701	2,133 New	2,133 $435,000

Q4 2021 Mar 02, 2022	SELL	$223.92 - $287.77 $229,294 - $294,676	-1,024 Closed	0 $0
Q4 2018 Feb 07, 2019	BUY	$278.5 - $352.75 $12,811 - $16,226	46 Added 4.7%	1,024 $308,000
Q3 2018 Oct 24, 2018	SELL	$293.51 - $383.83 $45,787 - $59,877	-156 Reduced 13.76%	978 $346,000
Q2 2018 Jul 30, 2018	SELL	$257.52 - $306.91 $64,895 - $77,341	-252 Reduced 18.18%	1,134 $329,000
Q1 2018 Apr 11, 2018	BUY	$260.13 - $367.91 $360,540 - $509,923	1,386 New	1,386 $380,000

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Capital Advisors Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on First Capital Advisors Group, Llc. with notifications on news.

Account

First Capital Advisors Group, Llc. Biogen Inc. Transaction History